Toward a Comprehensive Clinical Staging Model for Bipolar Disorder: Integrating the Evidence

被引:63
|
作者
Duffy, Anne [1 ,2 ]
机构
[1] Univ Calgary, Dept Psychiat, Campus Alberta Innovates Program, Calgary, AB T2N 4Z6, Canada
[2] Univ Calgary, Dept Psychiat, Mood Disorders Program, Calgary, AB T2N 4Z6, Canada
基金
加拿大健康研究院;
关键词
clinical staging; bipolar disorder; high-risk; natural history; heterogeneity; clinical course; developmental course; EARLY NATURAL-HISTORY; HIGH-RISK; MENTAL-DISORDERS; HIPPOCAMPAL VOLUMES; LITHIUM RESPONSE; MOOD DISORDERS; PSYCHOSIS; CHILDHOOD; DIAGNOSIS; SCHIZOPHRENIA;
D O I
10.1177/070674371405901208
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives: To describe key findings relating to the natural history and heterogeneity of bipolar disorder (BD) relevant to the development of a unitary clinical staging model. Currently proposed staging models are briefly discussed, highlighting complementary findings, and a comprehensive staging model of BD is proposed integrating the relevant evidence. Method: A selective review of key published findings addressing the natural history, heterogeneity, and clinical staging models of BD are discussed. Results: The concept of BD has broadened, resulting in an increased spectrum of disorders subsumed under this diagnostic category. Different staging models for BD have been proposed based on the early psychosis literature, studies of patients with established BD, and prospective studies of the offspring of parents with BD. The overarching finding is that there are identifiable sequential clinical phases in the development of BD that differ in important ways between classical episodic and psychotic spectrum subtypes. In addition, in the context of familial risk, early risk syndromes add important predictive value and inform the staging model for BD. Conclusions: A comprehensive clinical staging model of BD can be derived from the available evidence and should consider the natural history of BD and the heterogeneity of subtypes. This model will advance both early intervention efforts and neurobiological research.
引用
收藏
页码:659 / 666
页数:8
相关论文
共 50 条
  • [31] Staging and Neuroprogression in Bipolar Disorder
    Gabriel Rodrigo Fries
    Bianca Pfaffenseller
    Laura Stertz
    André Vinicius Contri Paz
    Aroldo Ayub Dargél
    Maurício Kunz
    Flávio Kapczinski
    Current Psychiatry Reports, 2012, 14 : 667 - 675
  • [32] Bipolar disorder: staging and neuroprogression
    Rodrigues, Aline Andre
    Rosa, Adriana R.
    Kunz, Mauricio
    Ascoli, Bruna
    Kapczinski, Flavio
    PSYCHIATRIA POLSKA, 2014, 48 (02) : 231 - 243
  • [33] Prognosis and staging in bipolar disorder
    Vieta, Eduard
    Reinares, Maria
    Ribeiro Rosa, Adriane
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2010, 38 : 35 - 38
  • [34] Neuroprogression and staging in bipolar disorder
    Zempulski, Priscila
    Castaldelli-Maia, Joao Mauricio
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2017, 63 (03) : 280 - 281
  • [35] Assessing and staging bipolar disorder
    Agius, Mark
    Rogers, Jonathan
    Bongards, Eva
    O'Connor, Stuart
    Verdolini, Norma
    Elisei, Sandro
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 204 (06) : 493 - 494
  • [36] Staging and Neuroprogression in Bipolar Disorder
    Fries, Gabriel Rodrigo
    Pfaffenseller, Bianca
    Stertz, Laura
    Contri Paz, Andre Vinicius
    Dargel, Aroldo Ayub
    Kunz, Mauricio
    Kapczinski, Flavio
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (06) : 667 - 675
  • [37] Soft Bipolar Spectrum and Staging in Bipolar Disorder
    Grande, Iria
    Frey, Benicio N.
    Vieta, Eduard
    Kapczinski, Flavio
    CURRENT PSYCHIATRY REVIEWS, 2013, 9 (01) : 33 - 40
  • [38] Bipolar disorder treatment: implications from the staging model perspective
    Silveira, L. E.
    Goi, P. D.
    Vianna-Sulzbach, M. F.
    Rosa, A. R.
    Panizzutti, B. S.
    Fries, G. R.
    Kunz, M.
    Gama, C. S.
    Kapczinski, F.
    Kauer-Sant'anna, M.
    BIPOLAR DISORDERS, 2012, 14 : 95 - 95
  • [39] Interleukin-6 as a biomarker of the model of staging in bipolar disorder
    Grande, I.
    Magalhaes, P. V.
    Chendo, I.
    Stertz, L.
    Rosa, A. R.
    Vieta, E.
    Kapczinski, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S291 - S292
  • [40] INTERLEUKIN-6 AS A BIOMARKER OF THE MODEL OF STAGING IN BIPOLAR DISORDER
    Grande, I.
    Magalhaes, P. V.
    Chendo, I.
    Stertz, L.
    Gama, C. S.
    Vieta, E.
    Kapczinski, F.
    EUROPEAN PSYCHIATRY, 2013, 28